|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | IGFBP-1 ELISA | Angiotensinogen Total ELISA Assay | a-Synuclein ELISA Assay | CCPlus: Anti-Cyclic Citrullinated ELISA Assay | Epstein-Barr Virus (EBNA-1) IgG ELISA |
| Citations | | | | | |
| Catalog Number | IB59128 | 27412 | 27740 | RA-96PLUS | IB79859 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the direct determination of Insulin-Like Growth Factor Binding Protein-1 in human serum. For research use only, not for diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Angiotensinogen ELISA in serum, EDTA-plasma, urine, or cell culture media. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination Human a-Synuclein in serum, EDTA plasma, CSF and cell culture supernatant. For research use only, not for use in diagnostic procedures. | The Immunoscan CCPlus test kit is an enzyme-linked immunosorbent assay (ELISA) for the determination of IgG antibodies to Cyclic Citrullinated Peptides (CCP) in human serum. 510(k) cleared, can be used for in-vitro diagnostics. | Enzyme immunoassay for the determination of IgG-class antibodies to Epstein-Barr virus nuclear antigen type 1 (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. |
| Detection Target | IGFBP-1 | Anti-Bevacizumab (Avastin®) | Histamine | Human T-Cadherin(100K, 130K) | SCC |
| Sample Type | Human serum. | Serum and plasma. | Blood Plasma, Urine | Human serum and EDTA-plasma. | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 1 - 250 µg/L | 0.31 to 20.00 ng/mL | 0.16 to 10.00 ng/mL | 25 to 3200 U/mL | A cut-off control is used for the interpretation of results. |
| Sensitivity | Inquire | 40 ng/mL | Plasma: 0.12 ng/mL; Urine: 0.30 ng/mL. | 0.009 ng/mL | Inquire |
| Assay Time | 30 min. incubation (RT) + 30 min. (RT) + 10 min. (RT) = 1 hour, 10 min. total incubation time. | 2 hrs (incubation) | Overnight + 1 hr 30 min. (incubation) | 2 hrs (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |